Earnings Preview: Kura Oncology (KURA) Q4 Earnings Expected to Decline

Kura Oncology (KURA) is expected to report a significant year-over-year decline in earnings and lower revenues for Q4 2025. The company is projected to post a quarterly loss of $0.72 per share, with revenues around $29.81 million. The Zacks Earnings ESP indicates a potential negative surprise, making it difficult to predict an earnings beat.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin